London, United Kingdom (PRWEB UK) 2 April 2015 -- LONDON – 31 March: Eli Lilly, PatientsLikeMe and Patient Power will demonstrate how they’re leveraging mobile, social media and connected devices to make clinical trials more efficient in an eyeforpharma webinar on April 24th.
Unexpected delays to clinical trials can cost millions. These delays are typically caused by failures in patient recruitment, retention and data collection. New technologies and social media can go a long way to solving these problems by boosting patient engagement and improving the integrity of the trial.
In fact, according to the latest eyeforpharma clinical survey, 51% of pharma execs think web-based patient portals will become increasingly important in recruiting patients over the next 2 years. And 43% think that dedicated social media has the power to transform patient recruitment.
In order to enhance patient-centricity in clinical trials, new technology-driven initiatives like these are being undertaken to make clinical trials participation less burdensome for patients and increase efficiencies in conducting trials.
These new techniques to drive recruitment, boost retention and improve data collection will be discussed in-depth during a 1 hour complimentary webinar, held later this month.
The webinar will be led by:
- Robert Kroes, Project Lead Clinical Open Innovation Europe for Eli Lilly
- Andrew Schorr, Cancer Survivor and Founder of Patient Power
- Jeremy Gilbert, VP Product for PatientsLikeMe
- And moderated by, Chris Shilling, Consultant, Innovation Vizier, Pharma Diagnostics, UK
Listeners of the webinar will find out how to use new technology and web-based portals to drive efficiencies in clinical trials. They’ll hear how to reduce the burden on patients to improve recruitment and retention. And finally, get insights on balancing regulation with patient-centric initiatives.
eyeforpharma have been the leader in networking events, in-depth reports and business intelligence for the pharmaceutical industry for the past 12 years. Originally, our community consisted solely of commercial (market access, sales and marketing) executives. However, after dozens of requests and in recognition of the increasing dominance of clinical trials towards company performance, we are investing heavily with clinical executives to help design more a patient-focussed operation. You can find more info here: http://www.eyeforpharma.com.
Helen Raff | Head of Clinical, Europe | eyeforpharma | Tel: +44 (0) 207 375 7582 | hraff(at)eyeforpharma(dot)com
Brittany Marshall, FC Business Intelligence, http://www.distribution-in-asset-management.com/index.php, +44 207 422 4369, [email protected]
SOURCE FC Business Intelligence